170 related articles for article (PubMed ID: 37972905)
1. Salvianolic acid B-loaded polydopamine-modified hollow mesoporous organic silica nanoparticles for treatment of breast cancer metastasis via suppressing cancer-associated fibroblasts.
Hu M; Cheng N; Wang S; Li R; Liu Y; Wang L; Chen W; Chen Y
Eur J Pharm Sci; 2024 Jan; 192():106641. PubMed ID: 37972905
[TBL] [Abstract][Full Text] [Related]
2. Acidity and Glutathione Dual-Responsive Polydopamine-Coated Organic-Inorganic Hybrid Hollow Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
Chen Q; Chen Y; Zhang W; Huang Q; Hu M; Peng D; Peng C; Wang L; Chen W
ChemMedChem; 2020 Oct; 15(20):1940-1946. PubMed ID: 32762008
[TBL] [Abstract][Full Text] [Related]
3. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
[TBL] [Abstract][Full Text] [Related]
4. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles.
He Q; Zhang J; Chen F; Guo L; Zhu Z; Shi J
Biomaterials; 2010 Oct; 31(30):7785-96. PubMed ID: 20674009
[TBL] [Abstract][Full Text] [Related]
5. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
6. pH-responsive glucosamine anchored polydopamine coated mesoporous silica nanoparticles for delivery of Anderson-type polyoxomolybdate in breast cancer.
Ramezani-Aliakbari M; Varshosaz J; Mirian M; Khodarahmi G; Rostami M
J Microencapsul; 2022 Aug; 39(5):433-451. PubMed ID: 35762905
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous Silicon Nanoparticles with Liver-Targeting and pH-Response-Release Function Are Used for Targeted Drug Delivery in Liver Cancer Treatment.
Wei J; Tan Y; Bai Y; He J; Cao H; Guo J; Su Z
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473773
[TBL] [Abstract][Full Text] [Related]
8. Complementary autophagy inhibition and glucose metabolism with rattle-structured polydopamine@mesoporous silica nanoparticles for augmented low-temperature photothermal therapy and
Shao L; Li Y; Huang F; Wang X; Lu J; Jia F; Pan Z; Cui X; Ge G; Deng X; Wu Y
Theranostics; 2020; 10(16):7273-7286. PubMed ID: 32641992
[TBL] [Abstract][Full Text] [Related]
9. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
11. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
Zhang K; Zhou D; Wang Z; Zhang Y; He P
Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
[TBL] [Abstract][Full Text] [Related]
12. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin Hydrochloride-Loaded Mesoporous Silica Nanoparticles Inhibit Non-Small Cell Lung Cancer Metastasis by Suppressing VEGF-Mediated Angiogenesis.
Zhang M; Jiang L
J Biomed Nanotechnol; 2016 Nov; 12(11):1975-86. PubMed ID: 29363936
[TBL] [Abstract][Full Text] [Related]
14. Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery.
Hadipour Moghaddam SP; Yazdimamaghani M; Ghandehari H
J Control Release; 2018 Jul; 282():62-75. PubMed ID: 29679666
[TBL] [Abstract][Full Text] [Related]
15. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.
Wei Y; Gao L; Wang L; Shi L; Wei E; Zhou B; Zhou L; Ge B
Drug Deliv; 2017 Nov; 24(1):681-691. PubMed ID: 28414557
[TBL] [Abstract][Full Text] [Related]
16. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
17. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
Li X; Xie C; Xia H; Wang Z
Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
[TBL] [Abstract][Full Text] [Related]
18. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
[TBL] [Abstract][Full Text] [Related]
19. A pH/ROS-responsive, tumor-targeted drug delivery system based on carboxymethyl chitin gated hollow mesoporous silica nanoparticles for anti-tumor chemotherapy.
Ding X; Yu W; Wan Y; Yang M; Hua C; Peng N; Liu Y
Carbohydr Polym; 2020 Oct; 245():116493. PubMed ID: 32718608
[TBL] [Abstract][Full Text] [Related]
20. Study of the anti-cancer activity of a mesoporous silica nanoparticle surface coated with polydopamine loaded with umbelliprenin.
Edalatian Tavakoli S; Motavalizadehkakhky A; Homayouni Tabrizi M; Mehrzad J; Zhiani R
Sci Rep; 2024 May; 14(1):11450. PubMed ID: 38769394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]